Antioxidant status of segmental and non-segmental vitiligo.

作者信息

Shajil E M, Begum Rasheedunnisa

出版信息

Pigment Cell Res. 2006 Apr;19(2):179-80. doi: 10.1111/j.1600-0749.2006.00299.x.

DOI:10.1111/j.1600-0749.2006.00299.x

PMID:16524434

Abstract

摘要

相似文献

Antioxidant status of segmental and non-segmental vitiligo.

Pigment Cell Res. 2006 Apr;19(2):179-80. doi: 10.1111/j.1600-0749.2006.00299.x.

Study on the antioxidant status of vitiligo patients of different age groups in Baroda.

Pigment Cell Res. 2004 Jun;17(3):289-94. doi: 10.1111/j.1600-0749.2004.00149.x.

Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo.

Int J Dermatol. 2002 Oct;41(10):640-2. doi: 10.1046/j.1365-4362.2002.01472.x.

Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo.

Clin Exp Dermatol. 2013 Oct;38(7):701-6. doi: 10.1111/ced.12054. Epub 2013 Apr 20.

Evaluation of the antioxidant status in vitiligo patients in Kashmir valley-a hospital based study.

Indian J Dermatol Venereol Leprol. 2013 Jan-Feb;79(1):100-1. doi: 10.4103/0378-6323.104678.

Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11-20 years.

Indian J Physiol Pharmacol. 2008 Jul-Sep;52(3):297-301.

Characterization of circulating CD8+T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo.

Eur J Dermatol. 2013 May-Jun;23(3):331-8. doi: 10.1684/ejd.2013.2011.

Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo.

Int J Dermatol. 2015 Jun;54(6):672-4. doi: 10.1111/ijd.12392. Epub 2014 Nov 27.

Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo.

Arch Dermatol Res. 2009 Oct;301(10):731-7. doi: 10.1007/s00403-009-0964-4. Epub 2009 Jun 2.

Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.

Saudi Med J. 2005 Jul;26(7):1085-91.

引用本文的文献

Metabolic anomalies in vitiligo: a new frontier for drug repurposing strategies.

Front Pharmacol. 2025 Apr 15;16:1546836. doi: 10.3389/fphar.2025.1546836. eCollection 2025.

Immunometabolism in the pathogenesis of vitiligo.

Front Immunol. 2022 Nov 10;13:1055958. doi: 10.3389/fimmu.2022.1055958. eCollection 2022.

Potential Role of Chronic Physical Exercise as a Treatment in the Development of Vitiligo.

Front Physiol. 2022 Mar 10;13:843784. doi: 10.3389/fphys.2022.843784. eCollection 2022.

A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.

Front Immunol. 2021 Feb 4;11:624566. doi: 10.3389/fimmu.2020.624566. eCollection 2020.

Autoimmunity in Segmental Vitiligo.

Front Immunol. 2020 Oct 27;11:568447. doi: 10.3389/fimmu.2020.568447. eCollection 2020.

Microalgae as Potential Anti-Inflammatory Natural Product Against Human Inflammatory Skin Diseases.

Front Pharmacol. 2020 Jul 31;11:1086. doi: 10.3389/fphar.2020.01086. eCollection 2020.

Glutathione Peroxidase Level in Patients with Vitiligo: A Meta-Analysis.

Biomed Res Int. 2016;2016:3029810. doi: 10.1155/2016/3029810. Epub 2016 Apr 27.

Oxidative stress and immune system in vitiligo and thyroid diseases.

Oxid Med Cell Longev. 2015;2015:631927. doi: 10.1155/2015/631927. Epub 2015 Mar 9.

Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo.

J Invest Dermatol. 2014 Aug;134(8):2221-2230. doi: 10.1038/jid.2014.152. Epub 2014 Mar 24.

Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.

PLoS One. 2012 Dec 20;7(12):e52298. doi: 10.1371/journal.pone.0052298.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验